Pub. L. 115-234, sec. 2 (as amended)

TABLE OF CONTENTS; REFERENCES IN ACT.

Year: 2023Length: 210 wordsOfficial source
SEC. 2. TABLE OF CONTENTS; REFERENCES IN ACT. (a) Table of Contents.—The table of contents for this Act is as follows: Sec. 1. 21 USC 301 note. Short title. Sec. 2. Table of contents; references in Act. TITLE I—FEES RELATING TO ANIMAL DRUGS Sec. 101. Short title; finding. Sec. 102. Definitions. Sec. 103. Authority to assess and use animal drug fees. Sec. 104. Reauthorization; reporting requirements. Sec. 105. Savings clause. Sec. 106. Effective date. Sec. 107. Sunset dates. TITLE II—FEES RELATING TO GENERIC ANIMAL DRUGS Sec. 201. Short title; finding. Sec. 202. Authority to assess and use generic new animal drug fees. Sec. 203. Reauthorization; reporting requirements. Sec. 204. Savings clause. Sec. 205. Effective date. Sec. 206. Sunset dates. TITLE III—MISCELLANEOUS PROVISIONS Sec. 301. Electronic submissions. Sec. 302. Index of legally marketed unapproved new animal drugs for minor species. Sec. 303. Misbranded drugs and devices. Sec. 304. Conditional approval of new animal drugs. Sec. 305. Guidance addressing investigation designs. Sec. 306. Food additives intended for use in animal food. (b) References in Act.—Except as otherwise specified, amendments made by this Act to a section or other provision of law are amendments to such section or other provision of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.).
Pub. L. 115-234, sec. 2 (as amended): TABLE OF CONTENTS; REFERENCES IN ACT. | Justis AI